莫氏显微手术对比广泛局部切除治疗侵袭性黑色素瘤的系统综述与荟萃分析
由于莫氏手术患者年龄更大、黑色素瘤更薄,现有数据无法可靠评估两种治疗方式在可比特征患者中的结局差异,需要随机试验证据。
要点
- 莫氏手术患者与广泛局部切除患者基线特征显著不同,前者年龄更大且黑色素瘤更薄。
- 两项比较研究报告黑色素瘤特异性死亡的调整风险比无显著差异。
- 局部复发风险未调整风险比为0.46(95%CI 0.14-1.51,P=0.20),异质性中等。
核心结论
- 基于现有数据,无法可靠评估特征可比的侵袭性黑色素瘤接受莫氏手术或广泛局部切除后结局是否不同。
- 需要随机试验证据才能得出可靠结论。
研究设计与样本
- 系统综述与荟萃分析,检索Embase、MEDLINE和Cochrane数据库至2023年8月30日。
主要发现
- 莫氏手术患者与广泛局部切除患者基线特征显著不同,莫氏手术患者年龄更大且黑色素瘤更薄。
- 两项使用相同数据源的比较研究报告黑色素瘤特异性死亡的调整风险比分别为0.87(95%CI 0.55-1.35)和1.20(95%CI 0.71-20.36),均无显著差异。
- 局部复发风险的未调整风险比为0.46(95%CI 0.14-1.51,P=0.20),异质性中等(I2=62%)。
- 无研究报道局部复发风险的多变量分析。
临床怎么用
- 目前证据不足以推荐莫氏手术替代广泛局部切除用于侵袭性黑色素瘤。
- 临床决策需考虑患者年龄、肿瘤厚度等基线特征差异。
局限性
- 许多研究来自相对较少且常重叠的数据集。
- 比较莫氏手术与广泛局部切除的研究较少,且两组间复发和死亡基线风险差异显著。
- 基于单变量分析的比较可能具有误导性。
- 缺乏随机试验证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of Mohs micrographic surgery (MMS) in melanoma treatment has divided opinion and evidence-based guidelines are lacking. OBJECTIVES: This systematic review aimed to analyse clinical outcomes for patients with invasive melanomas treated with Mohs rather than wide local excision (WLE). METHODS: Embase, MEDLINE and Cochrane databases (to 30 August 2023) were searched for studies using Mohs to treat invasive melanoma. Outcomes of interest were local recurrence and death from melanoma. RESULTS: Thirty-five articles involving 41,499 patients with invasive melanoma treated with Mohs were identified. Sixteen studies compared Mohs with WLE and 19 were Mohs-only, non-comparative studies. Patients treated with Mohs differed significantly from those undergoing WLE, in particular Mohs patients were older and had thinner melanomas. Two comparative studies using the same data source reported adjusted hazard ratios for melanoma-specific death and both showed no significant difference between Mohs and WLE-treated patients; 0.87 (95% CI 0.55-1.35) and 1.20 (95% CI 0.71-20.36). There was also no statistically significant difference in local recurrence risk; the unadjusted risk ratio for patients treated with Mohs was 0.46 (95% CI 0.14-1.51 p = 0.20) with moderate heterogeneity (I2 = 62%). No studies reported multivariable analyses for risk of local recurrence. Many studies generated from relatively few and often overlapping data sets have reported the use of Mohs to treat patients with invasive melanoma. Fewer studies were comparative between Mohs and WLE and these reported substantially different baseline risks of recurrence and death from melanoma between the groups. Mohs has generally been used for thinner melanomas in older patients; therefore, comparisons based on univariable analyses are likely to have been misleading. CONCLUSIONS: On the basis of currently available data, it is not possible to reliably assess whether outcomes differ if invasive melanomas with comparable features are treated with Mohs or WLE, and randomized trial evidence will be required for reliable conclusions to be reached.
引用
- Williams GJ, Quinn T, Lo S, et al. Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta-analyses. J Eur Acad Dermatol Venereol. 2024. PMID: 38842170. doi:10.1111/jdv.20138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。